Arabic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
eicosapentaenoic acid/التهاب
يتم حفظ الارتباط في الحافظة
الصفحة 1 من عند 35 النتائج
Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
This invention relates to the identification and uses of receptors that mediate anti-inflammatory activity, particularly to anti-inflammatory activity mediated by eicosapentaenoic acid analogs, and to uses of such receptors to screen candidate substances for anti-inflammatory
Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
This invention relates to the identification and uses of receptors that mediate anti-inflammatory activity, particularly to anti-inflammatory activity mediated by eicosapentaenoic acid analogs, and to uses of such receptors to screen candidate substances for anti-inflammatory
Ophthalmological composition of matter and a method for treatment of ocular inflammation by said composition
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
DESCRIPTION:
The present invention relates to a new ophthalmological composition, the active ingredient of which is eicosapentaenoic acid.
Eicosapentaenoic acid, abbreviated hereafter as "EPA", means cis-5, 8, 11, 14, 17-eicosapentaenoic acid of the formula ##STR1##
EPA is a known polyunsaturated
Methods for detecting inflammatory bowel disease in a feline
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for preventing or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
Method for preparing compositions for preventing or treating inflammatory bowel disease
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for presenting or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
The present invention relates generally to compositions and methods for preventing and/or treating inflammation and pain in patients and, more specifically, to compositions containing omega fatty acids and spirulina and to methods for their administration.
BACKGROUND OF THE
Compositions and methods for treating feline inflammatory bowel disease
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for preventing or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
CYP450 lipid metabolites reduce inflammation and angiogenesis
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
This invention relates to methods for reducing inflammation and angiogenesis, e.g., reducing or reversing angiogenesis, in a subject by administering a pharmaceutical composition comprising one or more epoxymetabolites derived from omega-3 long chain polyunsaturated fatty acids
CYP450 lipid metabolites reduce inflammation and angiogenesis
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
This invention relates to methods for reducing inflammation and angiogenesis, e.g., reducing or reversing angiogenesis, in a subject by administering a pharmaceutical composition comprising one or more epoxymetabolites derived from omega-3 long chain polyunsaturated fatty acids
Anti-inflammatory compositions containing monogalactosyl dieicosapentaenoyl glycerol and methods relating thereto
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
FIELD OF THE INVENTION
The invention relates generally to anti-inflammatory compositions and, more specifically, to anti-inflammatory compositions derived from marine algae having a high content of monogalactosyl dieicosapentaenoyl glycerol (MGDG-EPA.)
BACKGROUND OF THE
Anti-inflammatory compositions containing monogalactosyl dieicosapentaenoyl glycerol and methods of relating thereto
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
FIELD OF THE INVENTION
The invention relates generally to anti-inflammatory compositions and, more specifically, to anti-inflammatory compositions derived from marine algae having a high content of monogalactosyl dieicosapentaenoyl glycerol (MGDG-EPA).
BACKGROUND OF THE
Anti-inflammatory metabolite derived from omega-3-type fatty acid
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
TECHNICAL FIELD
The present invention relates to a novel anti-inflammatory compound.
BACKGROUND ART
Inflammatory disease, in the modern era, is one of the important disease fields for which countermeasures are necessary. Steroids, aspirin and ibuprofen, which are called nonsteroidal
Anti-inflammatory compounds
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
This application is a National Stage of PCT/JP10/052509 filed Feb. 19, 2010 and claims the benefit of JP 2009-037939 filed Feb. 20, 2009.
TECHNICAL FIELD
The present invention relates to a novel anti-inflammatory compound.
BACKGROUND ART
An inflammatory disease, in a modern era, is one of the
PHARMACEUTICALS, DIETARY SUPPLEMENTS AND COSMETIC COMPOSITIONS, AND THE USE OF CERTAIN MIXTURES FOR PREPARING A MEDICAMENT OR A DIETARY SUPPLEMENT FOR THE TREATMENT OR PREVENTION OF INFLAMMATION, HYPERSENSITIVITY REACTIONS OR PAIN
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
FIELD OF THE INVENTION
The present invention relates to mixtures comprising at least one of the fatty acids eicosapentaenoic acid (20:5n3) and docosahexaenoic acid (22:6n3) and the plant Zingiber officinale Roscoe or parts thereof or an extract or a component thereof
More specifically, the invention
PHARMACEUTICALS, DIETARY SUPPLEMENTS AND COSMETIC COMPOSITIONS, AND THE USE OF CERTAIN MIXTURES FOR PREPARING A MEDICAMENT OR A DIETARY SUPPLEMENT FOR THE TREATMENT OR PREVENTION OF INFLAMMATION, HYPERSENSITIVITY REACTIONS OR PAIN
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
Novel pharmaceuticals. dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain.
FIELD OF THE INVENTION
The present invention relates to
قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم
- يعمل في 55 لغة
- العلاجات العشبية مدعومة بالعلم
- التعرف على الأعشاب بالصورة
- خريطة GPS تفاعلية - ضع علامة على الأعشاب في الموقع (قريبًا)
- اقرأ المنشورات العلمية المتعلقة ببحثك
- البحث عن الأعشاب الطبية من آثارها
- نظّم اهتماماتك وابقَ على اطلاع دائم بأبحاث الأخبار والتجارب السريرية وبراءات الاختراع
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها.
* تستند جميع المعلومات إلى البحوث العلمية المنشورة
